Zuhal YETKİN AY, Recep SÜTÇÜ, Havva KOÇAK, Fatma Yeşim KIRZIOĞLU

Serum leptin levels and their proportional relationship with pro- and antiinflammatory mediators in aggressive periodontitis: preliminary report

To investigate the serum level of leptin (OB) and its relationship with pro- and antiinflammatory cytokines/mediators in aggressive periodontitis (AP) patients. Materials and methods: The study population (n = 12) comprised 6 AP patients and 6 periodontally healthy subjects (HC). The fasting venous serum samples were used to determine the OB and the cytokines/mediators belonging to the Th1/Th2/Th17 cells. The correlations among the OB and cytokines/mediators in the serum and clinical periodontal parameters were also investigated. Results: The AP group presented significantly higher serum TGF-b1 and IL-2 concentrations (pg/mL) and lower IL-4, IL-5, IL-12, IL-13, and IL-17A concentrations than the HC group (P < 0.05). The ratios of OB to IL-12, IL-13, and IL-17A were lower and the ratio of OB to TGF-b1 was higher in the AP than in the HC group (P < 0.05). Conclusion: Within the limitation of the small sample size, the results of our study are important in having determined the proportional relationship of OB with the pro- and antiinflammatory cytokines'/mediators' panel in AP patients. The usage of these kits in analyzing multiple cytokines/mediators might proportionally clarify the pathogenesis of AP.

Anahtar Kelimeler:

Key words: Aggressive periodontitis, leptin, cytokines

Serum leptin levels and their proportional relationship with pro- and antiinflammatory mediators in aggressive periodontitis: preliminary report

Keywords:

Key words: Aggressive periodontitis, leptin, cytokines,

PDF

___

Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K. Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol 1997; 12: 281–7.
Gemmell E, Winning TA, Grieco DA, Bird P, Seymour GJ. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice. J Periodontol 2000; 71: 1130–8.
Houri-Haddad Y, Wilensky A, Shapira L. T-cell phenotype as a risk factor for periodontal disease. Periodontol 2000 2007; 45: 67–
Ford PJ, Gamonal J, Seymour GJ. Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. Periodontol 2000 2010; 53: 111–23.
Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008; 87: 817–28.
Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2680–2.
Lexberg MH, Taubner A, Forster A, Albrecht I, Richter A, Kamradt T et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008; 38: 2654–64.
Zhang YR, Proence M, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–31.
Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-α. J Immunol 2004; 172: 1809–14.
Ahima RS, Flier JS. Leptin. Ann Rev Physiol 2000; 62: 413–37. Hristova M, Aloe L, Ghenev PI, Fiore M, Chaldakov GN. Leptin and mast cells: a novel adipoimmune link. Turk J Med Sci 2001; 31: 581–3.
Yetkin Ay Z, Kırzıoğlu FY, Öztürk Tonguç M, Sütçü R, Kapucuoğlu N. The gingiva contains leptin and leptin receptor in health and disease. Odontology 2012; 100: 222–31.
Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1–
Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21: 533–51.
Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odont Scand 1964; 22: 121–35.
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975; 25: 229–35.
Thunell DH, Tymkiw KD, Johnson GK, Joly S, Burnell KK, Cavanaugh JE et al. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res 2010; 45: 48–52.
Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, Chen S et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Ann Chem 2008; 80: 4741–51.
Trincheri G, Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol 1996; 59: 505–11.
Trincheri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev Immunol 2003; 3: 133–46. de Waal M, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL J Immunol 1993; 151: 6370–81.
Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ. T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol 1999; 44: 1045–53.
Shapira L, van Dyke TE, Hart TC. A localized absence of interleukin-4 triggers periodontal disease activity: a novel hypothesis. Med Hypotheses 1992; 39: 319–22.
Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467–76.
Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007; 78: 1083–93.
Gürkan A, Emingil G, Çınarcık S, Berdeli A. Gingival crevicular fluid transforming growth factor-β 1 in several forms of periodontal disease. Arch Oral Biol 2006; 51: 906–12.
Prime SS, Pring M, Davies M, Paterson IC. TGF-β signal transduction in oro-facial health and non-malignant disease (Part I). Crit Rev Oral Biol Med 2004; 15: 324–36.
Correa FOB, Gonçalves D, Figueredo CMS, Bastos AS, Gustafsson A, Orrico SRP. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol 2010; 37: 53–8. Filkova M, Haluzik M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 2009; 133: 157–70.